Catalyst Wire Dossier Catalyst Wire Dossier

intravitreal tPA

tissue plasminogen activator
Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for intravitreal tPA, covering 2020-07-14 to 2020-07-14. Get the full timeline:

Most recent: Clinical Trial Update: Intravitreal tPA and C3F8 for the Treatment of Submacular Haemorrhage as a Complication of Neovascular AMD [Phase 2, Phase 3]

See pricing